Clinical Trials Directory

Trials / Completed

CompletedNCT06468410

Effect of Hatha Yoga on Pulmonary Function

The Influence of Hatha Yoga Duration on Pulmonary Function in Sedentary Youth: An Acute and Four-Week Intervention Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Monira Aldhahi · Academic / Other
Sex
All
Age
15 Years – 18 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to to investigate the acute and chronic effects of a four-week hatha yoga (HY) exercise program with different durations (60 min and 30 min) on pulmonary function in sedentary young individuals.. The main questions it aims to answer are: • Does a four-week hatha yoga (HY) more effective than 30 min of a four-week hatha yoga (HY) and the control group in improving the pulmonary function? Researchers will compare a four-week OF 60 min duration hatha yoga (HY) , 30 min duration of HY and control to see the differences in the pulmonary function among high school sedentary students Participants will: Participants will be randomly assigned to one of three groups: 1. 60-minute Hatha Yoga group (60mHY, n=21) 2. 30-minute Hatha Yoga group (30mHY, n=21) 3. Control group (CG, n=21)

Detailed description

Objective: To investigate the acute and chronic effects of a four-week hatha yoga (HY) exercise program with different durations (60 minutes and 30 minutes) on pulmonary function in sedentary young individuals aged 15-16 years. Study Design: Randomized Controlled Trial (RCT) Participants: • Sample Size: 52 sedentary individuals Inclusion Criteria: * High school adolescence * Showed Sedentary lifestyle (defined as not participating in regular physical activity for at least 6 months. Exclusion Criteria: * Any known history of pulmonary, cardiovascular, or musculoskeletal conditions that would contraindicate exercise, * participation in any other exercise program during the study period * obesity (BMI \> 25.00) * Participants who are in medication that stimulate the heart of medication such as antibiotic use were excluded from the study Randomization: Participants will be randomly assigned to one of three groups: 4\. 60-minute Hatha Yoga group (60mHY, n=21) 5. 30-minute Hatha Yoga group (30mHY, n=21) 6. Control group (CG, n=21) Intervention: * 60mHY Group: Participants will undergo a 60-minute hatha yoga session twice a week for four weeks. * 30mHY Group: Participants will undergo a 30-minute hatha yoga session twice a week for four weeks. * Control Group: Participants will receive information about physical activity guidelines but will not engage in any structured yoga exercise during the study period. Outcome Measures: • Primary Outcome: Pulmonary function measured by spirometry.

Conditions

Interventions

TypeNameDescription
OTHERlong duration Hatha Yoga60 min of Hatha yoga for 4 weeks. Week One:Participants begin with foundational breathing and yoga practicesOn the second day, Square Breathwork is introduced to foster calm and concentration. After a warm-up, the yoga flow focuses on heart openers to increase chest and shoulder flexibility, ending with a soothing cool-down. Week Two:Advanced breathing techniques and targeted yoga flows are introduced. The second session includes Nadi Shodhana to balance the nervous system. Week Three:The focus remains on heart openers with varied breathing exercises. The second day revisits Full Yogic Breath, followed by a warm-up and another heart opener sequence, concluding with a cool-down. Week Four:The final week integrates additional breathing techniques. The last session features Kapalabhati and Suddhi Pranayama to purify and energize the body. After a warm-up, participants engage in a well-rounded yoga flow combining various poses to enhance overall fitness, concluding with a final cool-down.
OTHERshort duration Hatha Yoga30 min of Hatha yoga for 4 weeks .
OTHERControl groupparticipants will receive information about physical activity guidelines but will not engage in any structured yoga exercise during the study period.

Timeline

Start date
2023-01-01
Primary completion
2023-04-01
Completion
2023-12-01
First posted
2024-06-21
Last updated
2024-06-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06468410. Inclusion in this directory is not an endorsement.